Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
Tags:
gout, Selecta Biosciences, Sobi, SEL-212, 3SBio, Amgen, Arthrosi Therapeutics, Atom Bioscience, Dyve Biosciences, Hinova Pharmaceuticals, Horizon Therapeutics, InventisBio, Jiangsu Hengrui Pharmaceuticals, JW Group, LG Chem, Olatec Therapeutics, Shanton Bioscience
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Tags:
Amgen, Horizon Therapeutics, FTC, Regeneron, antitrust, M&A, Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
Tags:
FTC, M&A, Amgen, Horizon Therapeutics, Pfizer, Seagen, antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
Tags:
M&A, antitrust, Amgen, Astellas, Bellus Health, Globus Medical, GSK, Horizon Therapeutics, Merck, NuVasive, Pfizer, Prometheus Biosciences, Seagen
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Tags:
Amgen, Horizon Therapeutics, M&A, FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Tags:
Amgen, Horizon Therapeutics, FTC, M&A
Mirati's KRAS drug beats estimates in Q1, but Keytruda combo plan remains unclear
Fierce Pharma
Thu, 05/11/23 - 09:07 pm
Tags:
Mirati Therapeutics, Krazati, Amgen, Lumakras, lung cancer
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Tags:
Gilead Sciences, GSK, momelotinib, Roche, Eli Lilly, lebrikizumab, Merck, Zejula, Amgen, Galenica, Veltassa, Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs
Medical Marketing and Media
Tue, 05/9/23 - 11:24 pm
Tags:
Amgen, TScan, TargetScan, Crohn's Disease
Amgen, Entera ax $270M oral biologic pact 'out of mutual convenience'
Fierce Biotech
Mon, 05/8/23 - 10:17 am
Tags:
Amgen, Entera Bio
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Tags:
Amgen, Sandoz, legal, Prolia, Xgeva, patents, denosumab
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
Fierce Pharma
Wed, 05/3/23 - 10:29 pm
Tags:
Amgen, earnings, Horizon Therapeutics
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
Tags:
chronic hives, chronic urticaria, clinical trials, Sanofi, Regeneron, dupilumab, Amgen, tezepelumab, Allakos, lirentelimab, Celldex Therapeutics, barzolvolimab
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Fri, 04/28/23 - 10:46 am
Tags:
Amgen, earnings, Eli Lilly, lupus
Q1 revenues slide for Amgen, Gilead
Medical Marketing and Media
Thu, 04/27/23 - 10:54 pm
Tags:
Amgen, Gilead Sciences, earnings
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead Sceinces, JNJ, Merck, Pfizer, Regeneron, patents, activists
Amgen faces patent infringement claims on big-selling osteoporosis drug Evenity
Fierce Pharma
Tue, 04/25/23 - 10:10 pm
Tags:
Amgen, legal, patents, osteoporosis, Evenity, OssiFi-Mab
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen, Regeneron Pharmaceuticals, Sanofi, Supreme Court, patents, Pfizer, Bayer, Roche, Genentech, AstraZeneca, JNJ
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D, Amgen, Bayer, Biogen, Gilead Sciences, Merck KGaA, Moderna Therapeutics, Novo Nordisk, Regeneron Pharmaceuticals, UCB, Vertex Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.